Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly

Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.

For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Coty (COTY) Misses Q4 EPS by 1c, offers outlook
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance